Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03803774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03803774
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-25
- Primary completion
- 2023-11-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.